Pulm Circ. 2026 Mar 2;16(1):e70256. doi: 10.1002/pul2.70256. eCollection 2026 Jan.
ABSTRACT
In this first global study of patient perspectives in Group 2 and 3 PH, we demonstrate that those with Group 3 PH report significantly greater adverse impacts on physical and mental wellbeing than those in Group 2 or Group 1, despite a lower treatment side-effect profile.
PMID:41778265 | PMC:PMC12951357 | DOI:10.1002/pul2.70256
